Robocap Asset Management Ltd fully exited NICE, reducing its exposure by 4.5% of reported U.S. equity assets; post-trade stake is 0% of 13F AUM. Top holdings after this filing: NASDAQ: NVDA: $12.98 ...

The absorption of drugs taken by mouth can be limited by the physical conditions within the gastrointestinal (GI) tract. For example, the intestines are coated in layers of mucus designed to protect ...

In a recent study published in Science Robotics, a team of researchers led by the Massachusetts Institute of Technology (MIT) have developed a robotic drug capsule, which they dub “RoboCap”, designed ...

Some types of drugs are not effective as oral treatments and must be given as shots, like insulin. New technology that involves a tiny motor in a pill might make oral drug delivery possible for more ...

It is largely known that oral drug delivery for macromolecules is often limited by the degradative environment of the gastrointestinal tract. Researchers from the Massachusetts Institute of Technology ...

Researchers have developed a robotic pill that drills through mucus to help deliver medicine to the body. Screengrab of media release by Massachusetts Institute of Technology. The body is equipped ...

Robocap Asset Management Ltd fully exited NICE, reducing its exposure by 4.5% of reported U.S. equity assets; post-trade stake is 0% of 13F AUM. As of January 30, 2026, shares of NICE were priced at ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

An SEC filing dated February 2, 2026, shows Robocap Asset Management Ltd sold its entire holding of 34,940 shares in NICE during the fourth quarter. The estimated transaction value was $5.06 million, ...